ATE223711T1 - Tts enthaltend ein antioxidans - Google Patents
Tts enthaltend ein antioxidansInfo
- Publication number
- ATE223711T1 ATE223711T1 AT99902525T AT99902525T ATE223711T1 AT E223711 T1 ATE223711 T1 AT E223711T1 AT 99902525 T AT99902525 T AT 99902525T AT 99902525 T AT99902525 T AT 99902525T AT E223711 T1 ATE223711 T1 AT E223711T1
- Authority
- AT
- Austria
- Prior art keywords
- antioxidant
- ethyl
- tts
- contain
- tts contain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Fats And Perfumes (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Dental Preparations (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9800526.7A GB9800526D0 (en) | 1998-01-12 | 1998-01-12 | Organic compounds |
PCT/EP1999/000078 WO1999034782A1 (en) | 1998-01-12 | 1999-01-08 | Tts containing an antioxidant |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE223711T1 true ATE223711T1 (de) | 2002-09-15 |
Family
ID=10825116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99902525T ATE223711T1 (de) | 1998-01-12 | 1999-01-08 | Tts enthaltend ein antioxidans |
Country Status (26)
Country | Link |
---|---|
US (1) | US6335031B1 (de) |
EP (1) | EP1047409B1 (de) |
KR (1) | KR100569051B1 (de) |
CN (1) | CN1129427C (de) |
AT (1) | ATE223711T1 (de) |
AU (1) | AU745661B2 (de) |
BR (1) | BR9906920A (de) |
CA (1) | CA2315784C (de) |
CZ (1) | CZ300598B6 (de) |
DE (1) | DE69902875T2 (de) |
DK (1) | DK1047409T3 (de) |
ES (1) | ES2184408T3 (de) |
GB (1) | GB9800526D0 (de) |
HK (1) | HK1034036A1 (de) |
HU (1) | HU227159B1 (de) |
ID (1) | ID27503A (de) |
IL (1) | IL137100A (de) |
MX (1) | MXPA00006438A (de) |
NO (1) | NO328390B1 (de) |
NZ (1) | NZ505650A (de) |
PL (1) | PL201328B1 (de) |
PT (1) | PT1047409E (de) |
RU (1) | RU2219926C2 (de) |
SK (1) | SK284622B6 (de) |
TR (2) | TR200001688T2 (de) |
WO (1) | WO1999034782A1 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69923200T2 (de) * | 1998-10-01 | 2005-12-22 | Novartis Ag | Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe |
FR2793689B1 (fr) * | 1999-05-19 | 2001-08-24 | Pf Medicament | Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives |
RU2266735C2 (ru) * | 1999-11-29 | 2005-12-27 | Лтс Ломанн Терапи-Системе Аг | Трансдермальные терапевтические системы с повышенной стабильностью и способ их получения |
DE10107663B4 (de) * | 2001-02-19 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
ITMI20020798A1 (it) * | 2002-04-15 | 2003-10-15 | F T Holding S A | Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici |
FR2881653A1 (fr) * | 2005-02-04 | 2006-08-11 | Frederic Khodja | Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine |
TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
WO2009022345A1 (en) * | 2007-08-14 | 2009-02-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Phenyl carbamates for the treatment of multiple sclerosis |
PE20110591A1 (es) | 2008-07-28 | 2011-09-15 | Takeda Pharmaceutical | Composicion farmaceutica estabilizada a base de un compuesto no peptidico |
US20100087768A1 (en) * | 2008-10-02 | 2010-04-08 | Forlano Paula | Transdermal drug delivery system for liquid active ingredient |
US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
JP6083734B2 (ja) | 2009-12-22 | 2017-02-22 | リュイェ ファーマ アーゲーLuye Pharma AG | リバスチグミンまたはその誘導体を投与するための経皮治療システム |
ES2363395B1 (es) * | 2010-01-20 | 2012-02-23 | Farmalider, S.A. | Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral. |
WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
DE102010026903A1 (de) | 2010-07-12 | 2012-01-12 | Amw Gmbh | Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff |
SG10201505658RA (en) | 2010-07-21 | 2015-09-29 | 3M Innovative Properties Co | Transdermal adhesive compositions, devices, and methods |
ES2545094T3 (es) * | 2010-12-14 | 2015-09-08 | Acino Ag | Sistema terapéutico transdérmico para la administración de un principio activo |
KR101788802B1 (ko) * | 2010-12-24 | 2017-10-20 | 주식회사 삼양바이오팜 | 리바스티그민을 함유하는 경피흡수제제 |
KR20120126898A (ko) * | 2011-05-13 | 2012-11-21 | 에스케이케미칼주식회사 | 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물 |
KR20120130073A (ko) * | 2011-05-20 | 2012-11-28 | 에스케이케미칼주식회사 | 리바스티그민 함유 패취 |
WO2012161489A2 (ko) | 2011-05-20 | 2012-11-29 | 에스케이케미칼 주식회사 | 리바스티그민 함유 패취 |
EP2594261A1 (de) | 2011-11-18 | 2013-05-22 | Labtec GmbH | Zusammensetzung zur transdermalen Verabreichung von Rivastigmin |
DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
WO2013142339A1 (en) | 2012-03-23 | 2013-09-26 | Novartis Ag | Transdermal therapeutic system and method |
JP6153135B2 (ja) | 2012-06-12 | 2017-06-28 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
EP2893927A4 (de) * | 2012-09-03 | 2016-03-09 | Nipro Patch Co Ltd | Hautpflaster |
KR20140038237A (ko) | 2012-09-20 | 2014-03-28 | 에스케이케미칼주식회사 | 리바스티그민의 안정성이 개선된 의약품 |
WO2014051128A1 (ja) | 2012-09-28 | 2014-04-03 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
WO2014111790A2 (en) | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
CN106413695B (zh) * | 2014-04-08 | 2019-12-10 | 帝国制药美国公司 | 利伐斯的明透皮组合物及其使用方法 |
JPWO2015174502A1 (ja) | 2014-05-15 | 2017-05-25 | ニチバン株式会社 | リバスチグミンを含有する貼付剤のための包装体 |
KR20200025883A (ko) | 2018-08-31 | 2020-03-10 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
KR20200025888A (ko) | 2018-08-31 | 2020-03-10 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL195004C (nl) * | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
AU5716898A (en) * | 1997-01-08 | 1998-08-03 | Warner-Lambert Company | Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease |
EP0952826B1 (de) * | 1997-01-17 | 2001-11-14 | Takeda Chemical Industries, Ltd. | Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung |
-
1998
- 1998-01-12 GB GBGB9800526.7A patent/GB9800526D0/en not_active Ceased
-
1999
- 1999-01-08 ES ES99902525T patent/ES2184408T3/es not_active Expired - Lifetime
- 1999-01-08 TR TR2000/01688T patent/TR200001688T2/xx unknown
- 1999-01-08 PT PT99902525T patent/PT1047409E/pt unknown
- 1999-01-08 MX MXPA00006438A patent/MXPA00006438A/es active IP Right Grant
- 1999-01-08 RU RU2000120951/15A patent/RU2219926C2/ru active
- 1999-01-08 DK DK99902525T patent/DK1047409T3/da active
- 1999-01-08 NZ NZ505650A patent/NZ505650A/xx not_active IP Right Cessation
- 1999-01-08 PL PL341347A patent/PL201328B1/pl unknown
- 1999-01-08 ID IDW20001301A patent/ID27503A/id unknown
- 1999-01-08 EP EP99902525A patent/EP1047409B1/de not_active Expired - Lifetime
- 1999-01-08 WO PCT/EP1999/000078 patent/WO1999034782A1/en active IP Right Grant
- 1999-01-08 TR TR2001/01021T patent/TR200101021T2/xx unknown
- 1999-01-08 CN CN99802092A patent/CN1129427C/zh not_active Expired - Lifetime
- 1999-01-08 BR BR9906920-2A patent/BR9906920A/pt not_active Application Discontinuation
- 1999-01-08 KR KR1020007006433A patent/KR100569051B1/ko active IP Right Review Request
- 1999-01-08 SK SK1053-2000A patent/SK284622B6/sk not_active IP Right Cessation
- 1999-01-08 IL IL13710099A patent/IL137100A/en not_active IP Right Cessation
- 1999-01-08 CA CA002315784A patent/CA2315784C/en not_active Expired - Lifetime
- 1999-01-08 DE DE69902875T patent/DE69902875T2/de not_active Expired - Lifetime
- 1999-01-08 AU AU22785/99A patent/AU745661B2/en not_active Expired
- 1999-01-08 CZ CZ20002557A patent/CZ300598B6/cs not_active IP Right Cessation
- 1999-01-08 HU HU0004300A patent/HU227159B1/hu unknown
- 1999-01-08 AT AT99902525T patent/ATE223711T1/de active
- 1999-04-14 US US09/291,498 patent/US6335031B1/en not_active Expired - Lifetime
-
2000
- 2000-07-05 NO NO20003472A patent/NO328390B1/no not_active IP Right Cessation
-
2001
- 2001-04-20 HK HK01102834A patent/HK1034036A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE223711T1 (de) | Tts enthaltend ein antioxidans | |
PT1061900E (pt) | Composicoes e metodos para libertacao de uma droga | |
BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
ATE383849T1 (de) | Transdermale pharmazeutische zusammensetzung | |
AR037081A1 (es) | Composicion para el suministro transdermico de fentanilo | |
BR9405798A (pt) | Métodos para liberação in vivo de material biológico e composições úteis dos mesmos | |
ATE249422T1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
MA25681A1 (fr) | Systeme d'administration de compositions orales de soins comprenant une resine d'organosiloxane utilisant une bandelette de soutien amovible. | |
ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
MX9705954A (es) | Formulaciones y metodos para reducir irritacion de la piel. | |
ES2160163T3 (es) | Composiciones farmaceuticas a base de derivados de la clase de los taxanos. | |
MXPA05010607A (es) | Composiciones de distribucion de farmacos de ester de alfa-hidroxiacido y metodos de uso. | |
HRP20080178T3 (en) | Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances | |
DK1303278T3 (da) | Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme | |
EP1300143A4 (de) | Pflaster mit 4-biphenylessigsäure | |
TR200400241T4 (tr) | Lasofoksifen'in transdermal olarak verilmesi | |
GEP20094648B (en) | Anti-parasiticidal composition | |
IT1291895B1 (it) | Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo | |
ATE102934T1 (de) | Fluorierte flavon-essigsaeure. | |
TR200301552A1 (tr) | Rofekoksib' in yeni oral farmakolojik formülasyonları. | |
BR0214644A (pt) | Uso de derivados de ácido 4-oxobutanóico no tratamento de inflamação |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |